Impulse control disorders and Parkinson's disease;Troubles du contrôle des impulsions et maladie de Parkinson

Revue Medicale Suisse

Volumn 4, Issue 156, 2008, Pages 1145-1150

  Burkhard, Pierre R ^a   Catalano Chiuvé, Sabina ^a   Gronchi Perrin, Aline ^b   Berney, Alexandre ^b   Vingerhoets, François J G ^b   Lüscher, Christian ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; CLOZAPINE; PERGOLIDE; PERGOLIDE MESILATE; PRAMIPEXOLE; QUETIAPINE; ROPINIROLE; TRIHEXYPHENIDYL;

COMBINATION CHEMOTHERAPY; HUMAN; HYPERSEXUALITY; IMPULSE CONTROL DISORDER; PARKINSON DISEASE; REVIEW; ADULT; ARTICLE; MALE; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ADULT; HUMANS; IMPULSE CONTROL DISORDERS; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 44449110236     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. ** Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson's disease. Arch Neurol 2007;64:1089-96.
2. Merims D, Giladi N. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease. Parkinsonism Relat Disord 2008 (In Press).
3. O'Sullivan SS, Lees AJ. Pathological gambling in Parkinson's disease. Lancet Neurol 2007;6:384-6.
4. Wong SH, Steiger MJ. Pathological gambling in Parkinson's disease. Br Med J 2007;334:810-1.
5. McKeon A, Josephs KA, Klos KJ, et al. Unusual compulsive behaviors primarily related to dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord 2007;13:516-9.
6. Grosset KA, Macphee G, Pal G, et al. Problematic gambling on dopamine agonists : Not such a rarity. Mov Disord 2006;21:2206-8.
7. Molina JA, Sainz-Artiga MJ, Fraile A, et al. Pathologic gambling in Parkinson's disease : A behavioral manifestation of pharmacologic treatment? Mov Disord 2000; 15:869-72.
8. Voon V, Hassan K, Zurowski M, et al. Prospective prevalence of pathological gambling and medication association in Parkinson's disease. Neurology 2006;66: 1750-2.
9. Lu C, Bharmal A, Suchowersky O. Gambling and Parkinson disease. Arch Neurol 2006;63:298.
10. Avanzi M, Baratti M, Cabrini S, et al. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 2006;21:2068-72.
11. * Gallagher DA, O'Sullivan SS, Evans AH, Lees AJ, Schrag A. Pathological gambling in Parkinson's disease : Risk factors and differences from dopamine dysregulation. An analysis of published case series. Mov Disord 2007;22:1757-63.
12. Singh A, Kandimala G, Dewey Jr RB, O'Suilleabhain P. Risk factors for pathologic gambling and other compulsions among Parkinson's disease patients taking dopamine agonists. J Clin Neurosci 2007;14:1178-81.
13. Pontone G, Williams JR, Bassett SS, Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 2006;67;1258-61.
14. Dodd ML, Klos KJ, Bower JH, et al. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005;62:1377-81.
15. Szarfman A, Doraiswamy PM, Tonning JM, Levine JG. Association between pathologic gambling and parkinsonian therapy as detected in the Food and drug administration adverses event database. Arch Neurol 2006; 63:299-300.
16. Weintraub D, Siderowf AD, Potenza MN, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006;63:969-73.
17. Voon V, Hassan K, Zurowski M, et al. Prevalence of reward-based and repetitive behaviors in Parkinson's disease. Neurology 2006;67:1254-7.
18. * Driver-Dunckley ED, Noble BN, Hentz JG, et al. Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 2007;30:249-55.
19. Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 2007;68;301-3.
20. Pagonabarraga J, Garcia-Sanchez C, Llebaria G, et al. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord 2007; 22:1430-5.
21. * Isaias IU, Siri C, Cilia R, et al. The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord 2008;23:411-5.
22. Vogel HP, Schiffer R. Hypersexuality - a complication of dopaminergic therapy in Parkinson's disease. Pharmacopsychiatria 1983;16:107-10.
23. Nirenberg MJ, Waters C. Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 2006;21:524-9.
24. Macia F, Perlemoine C, Coman I, et al. Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight. Mov Disord 2004;19:206-12.
25. Montaurier C, Morio B, Bannier S, et al. Mechanisms of body weight gain in patients with Parkinson's disease after subthalamic stimulation. Brain 2007;130:1808-18.
26. * Schultz W, Dayan P, Montague PR. A neural substrate of prediction and reward. Science 1997;275: 1593-9.
27. D'Ardenne K, McClure SM, Nystrom LE, Cohen JD. BOLD responses reflecting dopaminergic signals in the human ventral tegmental area. Science 2008;319:1264-7.
28. Wagner FA, Anthony JC. From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol. Neuropsychopharmacology 2002;26:479-88.
29. Belin D, Everitt BJ. Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 2008; 57:432-41.
30. Giladi N, Weitzman N, Schreiber S, Shabtai H, Peretz C. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease : The role of dopamine agonist treatment and age at motor symptoms onset. J Psychopharmacol 2007;21:501-6.
31. ** Galpern WR, Stacy M. Management of impulse control disorders in Parkinson's disease. Curr Treat Options Neurol 2007;9:189-97.
32. * Mamikonyan E, Siderowf AD, Duda JE, et al. Long-term follow-up of impulse control disorders in Parkinson's disease. Mov Disord 2008;23:75-80.